Home › Trial NCT00523640
A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma
- Trial IDNCT00523640
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorUniversity of Chicago
- Enrollment30
- Start date2005-03
- ConditionsCarcinoma, Renal Cell
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.